That's a good point. There likely will be some am
Post# of 148050
(Total Views: 435)
Posted On: 01/25/2021 9:58:51 AM
Re: ClosetInvestor #74257
That's a good point. There likely will be some amount of ongoing sales related to COVID if this is endemic.
We will face competition, but recurring income will serve to set a floor for the share price.
If your estimate of $1 billion a year in sales results in $250mm in earnings, we should see a floor of 6.25-10 billion in market cap. ($8.92-$14.28).
This is a traditional evaluation, which doesn't hold in today's market. I would imagine in today's market it will be higher.
We will face competition, but recurring income will serve to set a floor for the share price.
If your estimate of $1 billion a year in sales results in $250mm in earnings, we should see a floor of 6.25-10 billion in market cap. ($8.92-$14.28).
This is a traditional evaluation, which doesn't hold in today's market. I would imagine in today's market it will be higher.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼